Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

ASX 200 closes higher after inflation cools; banks drag while Lynas jumps 14%

ASX 200 closes higher after inflation cools; banks drag while Lynas jumps 14%

The S&P/ASX 200 rose 0.15% to 8,695.6 Wednesday as miners and rare-earth stocks offset losses in banks after inflation slowed to 3.4% in November. Lynas Rare Earths surged 14.5% following China’s new export controls, while Commonwealth Bank, Westpac, ANZ, and NAB dropped up to 2%. The Australian dollar slipped to 67.28 U.S. cents. Investors await further CPI data due Jan. 28.
7 January 2026
·······
Mobileye stock jumps premarket after $900 million Mentee Robotics deal and new automaker win

Mobileye stock jumps premarket after $900 million Mentee Robotics deal and new automaker win

Mobileye Global shares rose 5.9% premarket after announcing a $900 million deal to acquire Mentee Robotics. The company expects to close the purchase in Q1 2026, paying $612 million in cash and up to 26.2 million shares. Mobileye also reported a major U.S. automaker will use its EyeQ6H-based Surround ADAS across models, boosting projected deliveries to over 19 million systems.
7 January 2026
··
BP stock slides in London as Trump-Venezuela crude deal weighs on oil prices

BP stock slides in London as Trump-Venezuela crude deal weighs on oil prices

BP shares dropped 3.1% in London after President Trump announced a deal for Venezuela to export up to 50 million barrels of crude to the U.S., pushing oil prices lower. BP continued its buyback program, purchasing about 3 million shares on Jan. 6. BP’s U.S. ADR fell 4.9% Tuesday. Traders are watching for more Venezuela news and BP’s Feb. 10 results.
7 January 2026
Moderna stock slides premarket after 11% surge on flu vaccine filings — what investors watch next

Moderna stock slides premarket after 11% surge on flu vaccine filings — what investors watch next

Moderna shares fell 1.4% to $35.15 premarket Wednesday after a 10.9% surge Tuesday, following news it filed for approval of its mRNA flu vaccine in the U.S., Europe, Canada, and Australia. The company reported 26.6% relative efficacy for the vaccine in adults 50 and older. Bayer’s Monsanto unit sued Moderna and other COVID-19 vaccine makers Tuesday, alleging mRNA patent infringement.
7 January 2026
··
Seagate stock (STX) slips in premarket after 14% jump as Nvidia CES storage push reshapes AI trade

Seagate stock (STX) slips in premarket after 14% jump as Nvidia CES storage push reshapes AI trade

Seagate shares fell 1.3% to $326 in premarket trading Wednesday after surging 14% Tuesday to $330.42, hitting a record high. The move followed Nvidia CEO Jensen Huang’s CES remarks on new AI storage technology, which also sent SanDisk, Western Digital, and Micron to all-time highs. CEO Dave Mosley sold 20,000 shares Jan. 2 under a pre-arranged plan, SEC filings show.
7 January 2026
··
Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge

Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge

Critical Metals Corp rose 9.2% to $12.90 in premarket trading Wednesday, extending a 25.6% gain from the previous session after renewed U.S. talk of acquiring Greenland. The company is developing the Tanbreez rare-earths project in southern Greenland. Investors are watching for U.S. jobs data and further signals from Washington. Greenland and Denmark have rejected any U.S. takeover.
7 January 2026
·
Western Digital stock dips in premarket after 17% jump as CES “AI storage” trade cools

Western Digital stock dips in premarket after 17% jump as CES “AI storage” trade cools

Western Digital shares fell 1.2% to $216.84 in premarket trading Wednesday, after surging 16.8% in the previous session. The move follows Nvidia CEO Jensen Huang’s comments at CES 2026 about unmet demand in memory storage for AI, which drove sharp gains across data-storage stocks. SanDisk jumped 28% and Seagate rose 14% Tuesday. Korean media reported Samsung and SK Hynix are raising server DRAM prices by up to 70% for the first quarter.
7 January 2026
·
Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical shares closed up 4.6% at $592.85 Tuesday and gained another 0.4% after hours. Evercore ISI raised its price target to $580, citing strong procedure and capital spending trends but kept an “In Line” rating. Trading volume reached 2.63 million shares. The company will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report earnings Jan. 22.
7 January 2026
··
NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest shares dropped 2.7% to 642.8 pence after Barclays downgraded the stock to “equal weight.” The bank continued its £750 million buyback, purchasing 787,737 shares Tuesday. Barclays trimmed 2026-27 earnings estimates by 4% and warned rising risk-weighted assets could limit surplus capital. Investors await NatWest’s Feb. 13 results for updates on margins and capital targets.
7 January 2026
··
1 … 238 239 240 241 242 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop